E-LIB Suche - Ergebnisse für: Chamorro, Carmen Martínez

1

COVID-19 Severity and Survival over Time in Patients with H..:

Martínez López, Joaquín ; De la Cruz, Javier ; Gil Manso, Rodrigo...
doi:10.3390/cancers15051497. , 2023

Link: https://hdl.handle.net/2..

2

Characteristics and Outcomes of Adult Patients in the PETHE..:

Martínez Cuadrón, David ; Serrano, Josefina ; Mariz, José...
CB16/12/00284. , 2022

Link: https://hdl.handle.net/2..

3

The probably use of MR-spectroscopy and diffusion weighted-..:

Martínez de Vega, Vicente ; Jiménez de la Peña, Mar ; Carrascoso, Javier...
Martínez-Vega, V., Jiménez-Pena, M., Carrascoso-Arranz, J., Rubio-Alonso, M., Bachiller-Egea, J., Martínez-Chamorro, C., & Recio-Rodríguez, M. (2021). The probably use of MR-spectroscopy and diffusion weighted-MRI of bone marrow for treatment monitoring in patients with chronic lymphatic leukemia. Annals of Bone Marrow Research, 6(1), 1–6. https://doi.org/10.17352/abmr.000007. , 2021

Link: http://hdl.handle.net/11..

4

Impact of the subcutaneous formulations of trastuzumab and ..:

María Reyes Abad-Sazatornil ; Ainhoa Arenaza ; Juan Bayo...
https://doi.org/10.1186/s12913-021-06277-8. , 2021

Link: https://doi.org/10.1186/..

5

Impact of the subcutaneous formulations of trastuzumab and ..:

Abad-Sazatornil, María Reyes ; Arenaza, Ainhoa ; Bayo, Juan...
http://hdl.handle.net/10668/17548. , 2021

Link: http://hdl.handle.net/10..

6

Impact of the subcutaneous formulations of trastuzumab and ..:

Abad-Sazatornil, María Reyes ; Arenaza, Ainhoa ; Bayo, Juan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8034176/. , 2021

Link: http://www.ncbi.nlm.nih...

7

Impact of the subcutaneous formulations of trastuzumab and ..:

Abad Sazatornil, María Reyes ; Arenaza, Ainhoa ; Bayó, Joan...
BMC Health Serv Res. 2021;21(1):320. ,

Link: http://hdl.handle.net/10..

8

Additional file 1 of Impact of the subcutaneous formulation..:

María Reyes Abad-Sazatornil (10574934) ; Ainhoa Arenaza (10574937) ; Juan Bayo (281170)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Impact_of_the_subcutaneous_formulations_of_trastuzumab_and_rituximab_on_efficiency_and_resource_optimization_in_Spanish_hospitals_H-Excelencia_study/14391300. , 2021

Link: https://doi.org/10.6084/..

9

COVID-19 Severity and Survival over Time in Patients with H..:

Joaquín Martínez-López ; Javier De la Cruz ; Rodrigo Gil-Manso...
https://www.mdpi.com/2072-6694/15/5/1497. , 2023

Link: https://doi.org/10.3390/..

10

COVID-19 Severity and Survival over Time in Patients with H..:

Joaquín Martínez-López ; Javier De la Cruz ; Rodrigo Gil-Manso...
Infectious Agents and Cancer. , 2023

Link: https://doi.org/10.3390/..

11

Real-World Outcomes of Belantamab Mafodotin for Relapsed/Re..:

Adrián Alegre ; Gonzalo Benzo ; Rafael Alonso...
https://doi.org/10.1007/s40487-022-00212-5. , 2022

Link: https://doi.org/10.1007/..

12

Characteristics and Outcomes of Adult Patients in the PETHE..:

David Martínez-Cuadrón ; Josefina Serrano ; José Mariz...
https://www.mdpi.com/2072-6694/14/11/2817. , 2022

Link: https://doi.org/10.3390/..

13

Characteristics and Outcomes of Adult Patients in the PETHE..:

David Martínez-Cuadrón ; Josefina Serrano ; José Mariz...
Cancer Epidemiology and Prevention. , 2022

Link: https://doi.org/10.3390/..

14

The probably use of MR-spectroscopy and diffusion weighted-..:

Vicente Martínez-Vega ; Mar Jiménez-Peña ; Javier Carrascoso-Arranz...
https://doi.org/10.17352/abmr.000007. , 2021

Link: https://doi.org/10.17352..

15

Impact of hematologic malignancy and type of cancer therapy..:

Julio García-Suárez ; Javier de la Cruz ; Ángel Cedillo...
http://link.springer.com/article/10.1186/s13045-020-00970-7. , 2020

Link: https://doi.org/10.1186/..